Developing Medical Innovation

We manufacture new medical technologies from the NHS and beyond to improve patient care

Revolutionary new technologies

Medovate is a dynamic medical device company dedicated to manufacturing innovative new medical devices and bringing them to market to help improve patient care.

We work closely with NHS clinicians and professionals to take their innovative ideas for new medical devices through the full development cycle including manufacturing, regulatory compliance and market launch.

The Medovate team comprises dedicated and experienced professionals, representing a significant number of years collective knowledge and expertise acquired through working in the medical technologies sector.

** COVID-19 pandemic: Medovate continues to remain fully open during this time with staff enabled to work from home. Please continue to contact us via phone and e-mail.****

Read More

Latest News

Keep up to date with Medovate News & Events


Medovate Silver Sponsors of RA-UK Annual Scientific Meeting 2021

21st April, 2021

Medovate are delighted to be a Silver Sponsor of the RA-UK Annual Scientific Meeting 2021, which is taking place on Wednesday 5th – Thursday 6th May 2021. Regional Anaesthesia - UK (RA-UK) have announced that, due to ongoing coronavirus restrictions, the event this year will be delivered virtually in a dynamic format. The two-day conference will be filmed in a TV style production and broadcast live from a venue in Sheffield.


REPLAY: Mitigating for Nerve Injury - patient safety and cost optimisation in regional anaesthesia

19th April, 2021

Medovate’s recent e-ESRA congress symposium ‘Mitigating for Nerve Injury by Innovation’ was a reminder that both improvements in patient safety and total cost optimisation are important considerations when introducing new technology to regional anaesthesia (RA). Sales and Marketing Director at Medovate, Chris Rogers looks at the key symposium takeaways.


Medovate partners with Pharmamed to evaluate SAFIRA® in Slovenia

6th April, 2021

Medovate is delighted to be partnering with Pharmamed to evaluate SAFIRA® (SAFer Injection for Regional Anaesthesia) in one of the largest healthcare institutions in Slovenia.